Skip to content

Characterization of Deqi Sensation and Acupuncture Effect

Yang et al. · Evidence-Based Complementary and Alternative Medicine · 2013

📖Review Article🧠NeuroimagingFoundational Concept

Evidence Level

MODERATE
75/ 100
Quality
4/5
Sample
3/5
Replication
4/5
🎯

OBJECTIVE

Review the knowledge on deqi (the arrival of qi sensation) in acupuncture and its relationship with therapeutic efficacy

👥

WHO

Patients and acupuncturists across multiple studies on needling sensation

⏱️

DURATION

Literature review through 2013

📍

POINTS

LI-4 (hegu), ST-36 (zusanli), LR-3 (taichong), TE-5 (waiguan)

🔬 Study Design

0participants
randomization

Review article

n=0

Analysis of the literature on deqi

⏱️ Duration: Historical review through 2013

📊 Results in numbers

< 1%

Cerebral response to deqi

Fast nerve fibers (numbness)

Aδ and C

Slow nerve fibers (dull ache)

Percentage highlights

< 1%
Cerebral response to deqi

📊 Outcome Comparison

Type of sensation

Traditional deqi
4
Sharp pain
1
💬 What does this mean for you?

Deqi is the distinctive sensation you may feel during acupuncture — such as numbness, heaviness, fullness, or dull aching. This study shows that this sensation may be important for treatment success, activating specific brain areas differently from common pain.

📝

Article summary

Plain-language narrative summary

This review article addresses one of the most fundamental concepts in traditional Chinese acupuncture: deqi, literally translated as 'arrival of vital energy.' Deqi represents a complex set of unique sensations experienced by both the patient and the acupuncturist during treatment. For the patient, it traditionally manifests as four principal sensations: suan (soreness or tenderness), ma (numbness or tingling), zhang (fullness, distention, or pressure), and zhong (heaviness). For the acupuncturist, deqi is perceived through the needle as a sensation of tension, tightness, and fullness, often described as 'a fish nibbling on the bait.' The review examines the considerable efforts made in recent years to develop standardized questionnaires that can adequately qualify and quantify the sensations of deqi. Several instruments have been developed, including the Vincent questionnaire (1989), the Park scale (2002), the Southampton questionnaire (SNSQ, 2008), and the Massachusetts General Hospital scale (MASS, 2007).

Each presents specific advantages and limitations, particularly in distinguishing genuine deqi from sharp pain, which is considered detrimental to treatment. Neuroimaging studies have revealed fascinating aspects of the cerebral mechanisms of deqi. Using functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), researchers have found that deqi activates distinct patterns in the brain, primarily deactivation of the limbic-paralimbic-neocortical system, whereas sharp pain provokes activation. The hypothalamus, insula, and subcortical structures emerge as important components in mediating the effects of acupuncture.

Notably, the magnitude of the cerebral response to deqi is small (less than 1%), suggesting that acupuncture operates within physiological limits, which may explain its few side effects. Investigation of the physiological mechanisms has revealed that different types of nerve fibers transmit the various sensations of deqi. Numbness is transmitted by the faster-conducting Aβ fibers, whereas dull aching, heaviness, and distention are transmitted by the slower-conducting Aδ and C fibers. Deqi has also been shown to affect blood flow with a certain degree of meridian specificity.

The crucial question of the relationship between deqi and clinical efficacy remains controversial. Although traditional Chinese medicine considers deqi essential for therapeutic success, controlled clinical studies have produced mixed results. Some studies have found positive correlations between the intensity of deqi and clinical outcomes, while others have found no significant differences between true acupuncture (with deqi) and sham acupuncture. This discrepancy may reflect methodological differences, patient populations, or even styles of acupuncture, since some traditions, such as Japanese acupuncture, intentionally avoid provoking intense sensations.

The review highlights several important limitations in the field. There is no consensus on a standard method or instrument for measuring deqi, despite considerable efforts. The subjective nature of deqi, influenced by cultural factors and individual expectations, presents significant methodological challenges. The lack of rigorously controlled clinical trials specifically designed to investigate the need for deqi for acupuncture efficacy represents a critical gap in knowledge.

Strengths

  • 1Comprehensive review of the developed deqi questionnaires
  • 2Integration of neuroimaging evidence with traditional theory
  • 3Critical analysis of current methodological limitations
  • 4Balanced discussion of physiological mechanisms
⚠️

Limitations

  • 1Lack of consensus on the standardized definition and measurement of deqi
  • 2Limited clinical evidence on the deqi-efficacy relationship
  • 3Influence of cultural factors not fully understood
  • 4Need for more specific controlled studies
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Deqi remains one of the most clinically relevant constructs in acupuncture, and this review offers a useful synthesis for physicians who must clearly communicate what happens physiologically during a session. Knowing that numbness and tingling are mediated by Aβ fibers, whereas heaviness, distention, and dull aching involve Aδ and C fibers, allows the acupuncturist to tailor needling technique according to the therapeutic goal and the patient's neurosensory profile. In conditions such as chronic low back pain, fibromyalgia, and tension-type headache, where central modulation is an essential component of treatment, understanding that deqi preferentially deactivates the limbic-paralimbic-neocortical system — the opposite pattern to sharp pain — supports choosing techniques that elicit deeper sensations. The small magnitude of the cerebral response reinforces the safety of the method, a relevant point for sensitized populations or for patients with comorbidities that limit pharmacologic use.

Notable Findings

The most noteworthy finding in this review is the dissociation between the cerebral activation patterns induced by deqi and by sharp pain. Whereas ordinary pain activates the limbic-paralimbic-neocortical system, deqi promotes its deactivation, with a prominent role for the hypothalamus, insula, and subcortical structures. This pattern converges with what we know about descending pain modulation and autonomic homeostasis, providing a neurobiological substrate for the sensation that classic texts describe as the arrival of qi. Equally relevant is the systematization of available questionnaires — from Vincent (1989) to MASS (2007) — which allows clinical researchers to select instruments according to the rigor required. The operational distinction between genuine deqi and sharp pain, which the tradition considers detrimental to therapeutic effect, finds support here in the different profiles of recruited nerve fibers.

From My Experience

In my practice at the Pain Center of HC-FMUSP, deqi is a routine technical parameter, not merely a theoretical concept. I typically observe that acupuncture-naive patients often mistake deep distention for something to avoid, and part of the work of the first session is to educate the patient to recognize deqi as a marker of well-positioned needling. In general, I see measurable clinical response after three to five sessions in musculoskeletal conditions, and we usually structure cycles of eight to twelve sessions before assessing maintenance. The profile that responds best, in my observation across decades, is the patient with chronic pain of predominantly central component, anxious but motivated — precisely the patient in whom the limbic deactivation described in this review makes the most therapeutic sense. I routinely combine acupuncture with physical therapy and, when indicated, with duloxetine or amitriptyline at low doses, leveraging the synergy of modulatory pathways. I avoid eliciting intense deqi in patients with marked allodynia or severe central sensitization syndrome, where the threshold is markedly lowered.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

Evidence-Based Complementary and Alternative Medicine · 2013

DOI: 10.1155/2013/319734

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.